We are live on ! Find out more
ANIK icon

Anika Therapeutics

162 hedge funds and large institutions have $465M invested in Anika Therapeutics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 49 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

37% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 49

11% more capital invested

Capital invested by funds: $417M → $465M (+$47.4M)

6% more funds holding

Funds holding: 153162 (+9)

1% more call options, than puts

Call options by funds: $4.03M | Put options by funds: $4M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
162
Holders Change
+9
Holders Change %
+5.88%
% of All Funds
4.66%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
67
Reduced
49
Closed
15
Calls
$4.03M
Puts
$4M
Net Calls
+$28K
Net Calls Change
+$1.87M
Name Holding Trade Value Shares
Change
Change in
Stake
AP
151
Advisors Preferred
Maryland
$24.8K +$23.8K +536 New
Teacher Retirement System of Texas
152
Teacher Retirement System of Texas
Texas
$24K
Bank of America
153
Bank of America
North Carolina
$19K -$297K -6,668 -94%
BlackRock
154
BlackRock
New York
$15K +$1.2K +27 +9%
TRCT
155
Tower Research Capital (TRC)
New York
$13K -$23.3K -524 -65%
MFS
156
MSI Financial Services
Massachusetts
$12K
MA
157
MCF Advisors
Kentucky
$10K
CCMH
158
Cornerstone Capital Management Holdings
New York
$9K +$8.89K +200 New
GC
159
Globeflex Capital
California
$3K -$2.09K -47 -39%
BNP Paribas Financial Markets
160
BNP Paribas Financial Markets
France
$2.41K +$400 +9 +21%
BRWA
161
B. Riley Wealth Advisors
Florida
$1.39K +$1.33K +30 New
GAM
162
Gemmer Asset Management
California
$1K +$489 +11 New
AIMCA
163
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$7.58M -184,507 Closed
OAM
164
Oxford Asset Management
United Kingdom
-$4.48M -108,953 Closed
Jane Street
165
Jane Street
New York
-$1.64M -39,868 Closed
HCMT
166
Highland Capital Management (Texas)
Texas
-$1.23M -30,000 Closed
VRS
167
Virginia Retirement Systems
Virginia
-$1.1M -26,800 Closed
PP
168
PDT Partners
New York
-$968K -23,557 Closed
SB
169
Suntrust Banks
Georgia
-$950K -23,142 Closed
Massachusetts Financial Services
170
Massachusetts Financial Services
Massachusetts
-$637K -15,510 Closed
CBOA
171
Commonwealth Bank of Australia
Australia
-$530K -12,891 Closed
RG
172
Renaissance Group
Kentucky
-$350K -8,504 Closed
D.E. Shaw & Co
173
D.E. Shaw & Co
New York
-$276K -6,196 Closed
DII
174
Domini Impact Investments
New York
-$245K -5,955 Closed
Axa
175
Axa
France
-$148K -3,600 Closed

ANIK Hedge Fund Activity: Q2 2014 in Review

162 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q2 2014, worth a combined $465M — up 11% from $417M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANIK positions and 15 closed out — a net gain of 9 holders — while 67 added to existing stakes and 49 trimmed.

The largest buyer was Thompson Siegel & Walmsley, adding an estimated $11.7M. The largest seller was Systematic Financial Management, cutting an estimated $26.4M.

  • 162 institutional investors held Anika Therapeutics (ANIK) as of Q2 2014, up from 153 in Q1 2014.
  • Funds reported $465M of Anika Therapeutics stock for Q2 2014, up 11% quarter-over-quarter.
  • 24 funds opened new Anika Therapeutics positions in Q2 2014 and 15 closed out, a net change of +9 holders.
  • The largest Anika Therapeutics buyer in Q2 2014 was Thompson Siegel & Walmsley, an estimated $11.7M added.
  • The largest Anika Therapeutics seller in Q2 2014 was Systematic Financial Management, an estimated $26.4M sold.

Based on aggregated 13F filings for Q2 2014.